Yogish C Kudva
Overview
Explore the profile of Yogish C Kudva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
181
Citations
3502
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kudva Y, Henderson R, Kanapka L, Weinstock R, Rickels M, Pratley R, et al.
Diabetes Technol Ther
. 2025 Mar;
PMID: 40067490
The Automated Insulin Delivery in Elderly with Type 1 Diabetes (AIDE T1D) trial randomized 82 adults ≥65 years with type 1 diabetes (T1D) to hybrid closed loop (HCL), predictive low...
2.
Sahi S, Garcia Valencia O, Na J, Lemke A, Duffy D, Smith B, et al.
Endocr Pract
. 2025 Mar;
PMID: 40054529
Objectives: Benefits of glucagon-like peptide-1 receptor agonists (GLP-1 RA) in kidney transplant recipients have not been adequately studied. Methods: We retrospectively examined the effects of GLP-1RA on mortality, kidney outcomes...
3.
Kukla A, Lester S, Iqbal A, Razonable R, Issa N, Riad S, et al.
Am J Transplant
. 2025 Jan;
PMID: 39828231
Treating acute rejection of a pancreas transplant in a severely immunocompromised patient with viral opportunistic infection is challenging due to the balance of rescuing from rejection without worsening the morbidity...
4.
Kudva Y, Henderson R, Kanapka L, Weinstock R, Rickels M, Pratley R, et al.
NEJM Evid
. 2024 Dec;
4(1):EVIDoa2400200.
PMID: 39714936
Background: Older adults with type 1 diabetes are at risk for serious hypoglycemia. Automated insulin delivery can reduce risk but has not been sufficiently evaluated in this population. Methods: We...
5.
Benhalima K, Mathieu C, Napoli A, Kudva Y, Cypryk K, Hammond P, et al.
Diabetes Technol Ther
. 2024 Nov;
27(2):91-92.
PMID: 39501847
No abstract available.
6.
Beck R, Levy C, Kudva Y, Pandit K, Blevins T, Raghinaru D, et al.
Clin Diabetes
. 2024 Oct;
42(4):547-549.
PMID: 39429449
No abstract available.
7.
Costa D, Kudva Y, Jensen M, Shah P
Diabetes Technol Ther
. 2024 Sep;
27(2):121-127.
PMID: 39226586
Serum C-peptide concentration is often utilized for diagnostic, prognostic, or therapeutic assessment in diabetes mellitus. However, there are limited clinical data regarding diagnostic and predictive value of C-peptide measured during...
8.
Hirsch I, Beck R, Marak M, Calhoun P, Mottalib A, Salhin A, et al.
Diabetes Care
. 2024 Jul;
47(9):1682-1687.
PMID: 39042575
Objective: To compare postprandial glucose excursions following a bolus with inhaled technosphere insulin (TI) or subcutaneous rapid-acting analog (RAA) insulin. Research Design And Methods: A meal challenge was completed by...
9.
Long J, Sahi S, Lemke A, Na J, Garcia Valencia O, Budhiraja P, et al.
Endocr Pract
. 2024 Jul;
30(10):963-969.
PMID: 39025300
Objective: Semaglutide, a glucagon-like peptide-1 receptor agonist is approved for weight loss and diabetes treatment, but limited literature exists regarding semaglutide use in patients with advanced chronic kidney disease (CKD)....
10.
Gleeson F, Dunleavy K, Levy M, Carr R, Hartgers M, Kottschade L, et al.
Pancreas
. 2024 Jul;
53(7):e627-e629.
PMID: 38986081
No abstract available.